Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Alan D Frazier Net Worth & Insider Trades

Alan D Frazier - Director, Rigel Pharmaceuticals Inc

As of January 26, 2005

What is Alan D Frazier's Net Worth?

The current estimated net worth of Rigel Pharmaceuticals Inc's Director, Alan D Frazier, is estimated to be about $225.95M . Alan D Frazier owns about 10,905 units of Rigel Pharmaceuticals Inc common stock. In the last year at Rigel Pharmaceuticals Inc, Alan D Frazier has sold an estimated value of $3.12M worth.

What is Alan D Frazier's Past Insider Trading?

Alan D Frazier's largest sale order was 78,436 units , worth over $1.47M on February 23, 2004. In total, Alan D Frazier has made about 5 transactions over a year of their time at Rigel Pharmaceuticals Inc. Alan D Frazier usually trades in February, with the busiest year in 2004. The most recent transaction was a sale order of 943,291 units , worth over $44.54K on January 26, 2005.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ALAN FRAZIER

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Rigel Pharmaceuticals Inc's Past Insider Trades?

Rigel Pharmaceuticals Inc's most recent insider trade came on February 7, 2023 by Raul Rodriguez who sold 20,340 units worth $35.59K . In the last 19 years, insiders at Rigel Pharmaceuticals Inc have sold an estimated value of $206.58M and bought an estimated value of $21.84M worth of shares. Insider trading is most common in May, with the busiest year in 2004. The most active traders at the company are Raul Rodriguez, CEO,  Dolly Vance, EVP Corp. Affairs,  and Jean Deleage, Director .

RIGEL PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...